ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,468Medicare Part D Prescriptions Filled, Including Refills

Rank: 205 out of 2456

$497K Total Retail Price of All Prescriptions

Rank: 234 out of 2456

518 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 518 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 518 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,695 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 589 441 1 2
OMEPRAZOLE 428 239 2 3
LISINOPRIL 414 350 3 1
METFORMIN HCL 274 213 4 11
LEVOTHYROXINE SODIUM 245 190 5 4
AMLODIPINE BESYLATE 225 197 6 5
HYDROCHLOROTHIAZIDE 222 198 7 7
ATORVASTATIN CALCIUM 212 183 8 12
ATENOLOL 194 155 9 6
RANITIDINE HCL 190 94 10 31
FUROSEMIDE 187 148 11 8
METOPROLOL TARTRATE 152 136 12 10
ZOLPIDEM TARTRATE 146 110 13 28
FLUTICASONE PROPIONATE 145 115 14 30
ALENDRONATE SODIUM 144 103 15 19
ALLOPURINOL 137 112 16 27
HYDROCODONE-ACETAMINOPHEN 137 46 S3 16 20
TRAMADOL HCL 135 102 18 24
GLIMEPIRIDE 134 103 19 74
ZETIA 121 73 20 86
METOPROLOL SUCCINATE 121 105 20 13
FLUOXETINE HCL 113 74 22 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 55 23 41
PANTOPRAZOLE SODIUM 104 41 24 37
CITALOPRAM HBR 103 97 25 14
PROAIR HFA 102 52 26 22
IBUPROFEN 99 28 27 52
DONEPEZIL HCL 97 97 28 23
AZITHROMYCIN 91 71 29 60
LOVASTATIN 90 64 30 34
LOSARTAN POTASSIUM 86 74 31 18
ESCITALOPRAM OXALATE 81 59 32 116
GABAPENTIN 73 39 33 16
SERTRALINE HCL 72 45 34 21
CRESTOR 72 56 34 25
OXYCODONE-ACETAMINOPHEN 67 38 S2 36 35
ROPINIROLE HCL 65 22 37 148
POTASSIUM CHLORIDE 61 50 38 33
TRAZODONE HCL 58 36 39 17
GLYBURIDE 58 47 R 39 40
LIPITOR 57 36 41 63
WARFARIN SODIUM 55 51 42 9
BENICAR 55 49 42 160
ADVAIR DISKUS 53 35 44 36
TAMSULOSIN HCL 53 45 44 32
PRAVASTATIN SODIUM 51 48 46 15
METFORMIN HCL ER 51 41 46 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.